Gross Margin: A company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage. Calculated as: Gross Income / Total Revenues
Evofem Biosciences, Inc. (EVFM) had Gross Margin of 77.12% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$20.18M |
|
$0.27M |
|
$4.62M |
|
$15.57M |
|
$16.81M |
|
$3.37M |
|
$-2.98M |
|
$0.39M |
|
$0.39M |
|
$0.39M |
|
$0.39M |
|
$0.39M |
|
$0.39M |
|
$3.37M |
|
$4.00M |
|
123.66M |
|
6.42B |
|
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$15.28M |
|
$0.42M |
|
$4.99M |
|
$20.27M |
|
$84.82M |
|
-- |
|
$4.89M |
|
$89.71M |
|
$-74.34M |
|
$-73.78M |
|
$-69.44M |
|
126.69M |
|
| Cash Flow Statement Financials | |
$-1.99M |
|
$-0.06M |
|
$1.89M |
|
$0.74M |
|
$0.58M |
|
$-0.16M |
|
$0.17M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.18 |
|
-- |
|
-- |
|
-- |
|
-0.78 |
|
|
Gross Margin |
77.12% |
16.71% |
|
16.71% |
|
19.81% |
|
1.95% |
|
1.36% |
|
$-2.05M |
|
-- |
|
-- |
|
-- |
|
1.00 |
|
4.09 |
|
1.62 |
|
225.69 |
|
-0.53% |
|
-0.53% |
|
1.93% |
|
-0.56% |
|
$-0.55 |
|
$-0.00 |
|
$-0.00 |
|